CorrespondenceJournal of Pharmacology and PharmacotherapeuticsVol. 2 | Issue 4 | 2011 | pp. 308–309Open access
World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies
- 1*
- 1 et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: B. Gitanjali
et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
Email: gitabatman@gmail.com
Copyright: © 2011 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2011
How to cite
Gitanjali, B. (2011). World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 308–309. https://doi.org/10.4103/0976-500X.85943
Abstract
On May 31, 2011, Hans Hogerzeil, Director of Essential Medicines and Pharmaceutical Policies, World Health Organization (WHO), Geneva, received a touching sendoff from the staff and colleagues of WHO, an agency which he had served for 26 years. Hans received his medical degree from the University of Leiden, The Netherlands, and spent his early years as a doctor in India, working in a leprosy mission hospital, and later in a hospital in Ghana, Africa. Hans joined the WHO’s Regional Offi ce for the Eastern Mediterranean (EMRO) in Alexandria, Egypt, in 1985 and worked with Prof. Ranjit Roy Chaudhury for a few years. Later, he joined the WHO Action Programme on Essential Drugs at the WHO headquarters in Geneva and went on to become the Director of Essential Medicines and Pharmaceutical Policies. Hans played a vital role in building on and strengthening the edifi ce built by stalwarts of the essential drugs movement, like Mahler, Lauridsen and Helling-Borda. Hans is well known in India for his book “A guide to good prescribing”, which has been translated into many languages, and its sister publication, “A teacher’s guide to good prescribing”.
Keywords
Subject
Article metadata
| Title | World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies |
|---|---|
| Authors | B. Gitanjali |
| Affiliations | et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4. |
| Corresponding author | gitabatman@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 2, Issue 4 (2011) |
Also in this issue
- ACE inhibitor and angiotensin-receptor blocker – A deadly combinationpp. 311–312
- The National Formulary of India 2010: Thorough and extensive revision of the preprint version neededpp. 219–20
- Research publications: Should they be mandatory for promotions of medical teachers?pp. 221–222
- The curious case of zinc for diarrhea: Unavailable, unprescribed, and unusedpp. 225–226
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellituspp. 230–235
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026